Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.54 CNY -2.46% Market Closed
Market Cap: 99.7B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note
Shanghai RAAS Blood Products Co Ltd
/
Cash Flow Statement
/
Capital Expenditures

Shanghai RAAS Blood Products Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai RAAS Blood Products Co Ltd
Capital Expenditures Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Capital Expenditures
-¥497.9m
CAGR 3-Years
-26%
CAGR 5-Years
-39%
CAGR 10-Years
-20%
Beigene Ltd
HKEX:6160
Capital Expenditures
-¥4.1B
CAGR 3-Years
-61%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Capital Expenditures
-¥1.4B
CAGR 3-Years
-17%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Capital Expenditures
-¥1.2B
CAGR 3-Years
-44%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Capital Expenditures
-¥1B
CAGR 3-Years
14%
CAGR 5-Years
-14%
CAGR 10-Years
-16%
Imeik Technology Development Co Ltd
SZSE:300896
Capital Expenditures
-¥63.7m
CAGR 3-Years
-26%
CAGR 5-Years
-10%
CAGR 10-Years
N/A

See Also

What is Shanghai RAAS Blood Products Co Ltd's Capital Expenditures?
Capital Expenditures
-497.9m CNY

Based on the financial report for Jun 30, 2024, Shanghai RAAS Blood Products Co Ltd's Capital Expenditures amounts to -497.9m CNY.

What is Shanghai RAAS Blood Products Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-20%

Over the last year, the Capital Expenditures growth was -76%. The average annual Capital Expenditures growth rates for Shanghai RAAS Blood Products Co Ltd have been -26% over the past three years , -39% over the past five years , and -20% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 198,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.